SR9009 bodybuilding The dominant search intent for "sr 9009 peptide" is to understand what the compound is, its mechanism of action, and its potential effects, particularly concerning metabolism, weight loss, and athletic performance.SR9009 - Cayman Chemical There's also an underlying interest in its status as a research chemical, its properties, and how it's used in research contexts.SR9009 | CAS NO.:1379686-30-2
Tier 1 Entities and Phrases:
* SR9009 (Stenabolic)
* REV-ERB agonist
* Metabolism
* Weight loss
* Endurance
* Research drug/chemical
* Agonist of Rev-ErbA/Rev-Erb alpha/beta
* SR9009 improves fatty acid oxidation and glucose metabolism
Tier 2 Entities and Phrases:
* Circadian rhythm
* Transcription
* Synthetic compound
* Obesity
* Diabetes
* Athletic performance
* NR1D1
* Heart function
* Liver pathology
* Inflammation
* Dosage
* Purity
* SARM (often mentioned in relation, though SR9009 is not a SARM)
Tier 3 Entities and Phrases:
* Bisphenol A
* NASH
* TLR signaling pathways
* Chemotherapeutic effect
* Bipolar, anxiety and depressive disorders (less prominent in SERP for SR9009 itself)
* Specific product names or brands (unless central to understanding the compound)
* "Promo"
---
SR9009, often referred to as Stenabolic, is a synthetic research chemical that functions as a potent agonist for the REV-ERB alpha and beta receptors.REV-ERB agonism improves liver pathology in a mouse model of NASH These receptors play a crucial role in regulating the body's circadian rhythms, metabolism, and inflammation.SR9009, also known as Stenabolic,is a research drugthat was developed by professor Thomas Burris of the Scripps Research Institute as an agonist of Rev-ErbA. As a REV-ERB agonist, SR9009 influences the constitutive repression of genes controlled by these receptors, leading to significant impacts on various physiological processes.2018年4月19日—SR-9009 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, ... Research indicates that SR9009 can improve both fatty acid oxidation and glucose metabolism, making it a compound of interest for studies related to metabolic diseases, weight management, and energy expenditure.
The primary mechanism of SR9009 involves its action as a REV-ERB agonistChemotherapeutic Effect of SR9009, a REV-ERB Agonist .... REV-ERBs are nuclear receptors that are part of the core transcriptional feedback loops regulating the body's internal clock. By binding to and activating REV-ERB alpha and beta, SR9009 enhances their repressive activity on target genesBuySR9009 agonist(MBS3845326) product datasheet at MyBioSource, Agonists.. This leads to a cascade of effects that can alter metabolic pathways.REV-ERBα Agonist SR9009 Promotes a Negative Energy ... For instance, it has been shown to increase the expression of genes involved in glucose metabolism and fatty acid breakdown, effectively promoting a negative energy balance. This action is distinct from selective androgen receptor modulators (SARMs), although SR9009 is sometimes discussed in similar contexts due to its research applications.
Much of the interest in SR9009 stems from its observed effects on metabolism and body composition in preclinical studiesInduces weight loss in diet-induced obese mice. Brain penetrant. Compound Libraries for SR 9009. SR 9009 is also offered as part of the Tocriscreen 2.0 Max.. Research in animal models has demonstrated that SR9009 can:
* Induce Weight Loss: By increasing metabolic rate and promoting the utilization of stored fats, SR9009 has shown efficacy in reducing body weight in diet-induced obese models. This is largely attributed to its influence on fatty acid oxidation.
* Improve Glucose Metabolism: Studies suggest that SR9009 can enhance glucose uptake and utilization, potentially offering benefits for conditions related to glucose dysregulation.
* Enhance Endurance: The compound has been investigated for its ability to improve athletic performance, likely due to its effects on mitochondrial biogenesis and energy metabolism within muscle tissues.2023年10月19日—SR9009 improves both fatty acid oxidation and glucose metabolism. This dual action prevents excess glucose from converting into fat and helps ...
* Mitigate Inflammation: REV-ERB agonists like SR9009 have been explored for their anti-inflammatory properties, with some studies showing a reduction in inflammatory markersSR9009, also known as Stenabolic,is a research drugthat was developed by professor Thomas Burris of the Scripps Research Institute as an agonist of Rev-ErbA..
* Support Liver Health: Research has also explored its role in improving liver pathology, particularly in models related to metabolic dysfunction.
It is critical to understand that SR9009 is classified as a research chemical. It is not approved for human consumption by any regulatory agency, and its use outside of laboratory research settings carries significant risks. Scientific studies utilize SR9009 primarily to investigate the complex roles of REV-ERB receptors in physiology, from metabolic control and circadian rhythm regulation to potential therapeutic applications in diseases like obesity, diabetes, and certain inflammatory conditions.Buy SR-9009 Stenabolic | Free Next-Day Delivery The compound is synthesized for laboratory use, and its availability is typically from specialized chemical suppliers catering to researchers.作者：PM Wagner·2019·被引用次数：51—A synthetic pyrrole derivative (SR9009) that acts as REV-ERBs-specific agonists exhibits potent in vivo activity on metabolism and tumor cell viability.
While preclinical studies highlight promising effects, it is crucial to acknowledge the limitations and potential concerns surrounding SR9009:
* Lack of Human Trials: The vast majority of research on SR9009 has been conducted in vitro or in animal modelsSr9009 Sarms Stenabolic PeptidesCAS NO.1379686-30-2 For Bodybuilding ... Hydrolysed Fish Collagen Peptide, Packaging Type : Carton. ₹ 1,300 .... There is a significant lack of robust clinical data on its safety, efficacy, and long-term effects in humans.
* Research Use Only: Suppliers of SR9009 explicitly state that it is for research purposes only and not for human or veterinary use.SR9009 | 1379686-30-2 | FS159307 This designation underscores its experimental statusSR9009 improves heart function after pressure overload independent of ....
* Dosage and Purity: For researchers, understanding precise dosages and ensuring the purity of the compound are paramount for obtaining reliable experimental results. Various suppliers may offer different purity levels and formulations.SR 9009 | Rev-Erb Receptors
* Comparison to SARMs: Although sometimes grouped with SARMs in discussions about performance enhancement, SR9009 is mechanistically differentSR9009, also known as Stenabolic,is a research drugthat was developed by professor Thomas Burris of the Scripps Research Institute as an agonist of Rev-ErbA.. It acts on nuclear receptors involved in metabolic regulation rather than androgen receptors.
In conclusion, SR9009 is a synthetic REV-ERB agonist that has garnered attention for its profound effects on metabolism, particularly in promoting fatty acid oxidation and glucose utilization, and its potential to influence endurance. However, its status as a research chemical means that its application is confined to scientific investigation, and comprehensive human safety and efficacy data are absent.
Join the newsletter to receive news, updates, new products and freebies in your inbox.